机器人辅助肾移植:欧洲8年经验
该回顾性分析基于2015年7月至2023年10月欧洲十中心前瞻性多中心队列,纳入624例活体供肾异位机器人辅助肾移植患者,评估围手术期结果与长期肾功能。中位随访23个月,围手术期并发症少见,长期功能结果良好,主要局限为缺乏对照组。
要点
- 624例活体供肾机器人辅助肾移植,中位年龄35岁,52%为抢先移植。
- 中位手术时间210分钟,再灌注温缺血时间43分钟,术中并发症发生率1.1%。
- 早期和晚期高级别(Clavien-Dindo≥3级)并发症分别为7.7%和2.3%,移植肾切除率1.9%。
核心结论
- 基于全球最大样本量的机器人辅助肾移植经验,证实该手术围手术期安全且长期功能结果优异。
- 鉴于微创机器人入路的优势,这些发现支持将机器人辅助肾移植作为肾移植的可行选择更广泛地采用。
研究设计与样本
- 回顾性分析,基于2015年7月至2023年10月欧洲十中心前瞻性多中心队列研究。
- 纳入624例接受活体供肾异位机器人辅助肾移植的患者,排除原位机器人辅助肾移植者。
- 主要结局为长期肾功能(估算肾小球滤过率eGFR)、围手术期并发症和生存率;采用Clavien-Dindo分类(CDC)描述早期(30天内)和晚期(31至90天)术后并发症;随访期间透析、移植肾切除和任何原因死亡的概率以5年累积发生率报告。
主要发现
- 624例患者中位年龄35岁(四分位距IQR:26-52),52%为抢先机器人辅助肾移植,84%移植肾置于右髂窝。
- 中位手术时间210分钟(IQR:180-262),再灌注温缺血时间43分钟(IQR:38-50);术中并发症发生率1.1%,术后移植肾切除发生率1.9%。
- 早期和晚期高级别(CDC≥3级)术后并发症分别见于7.7%和2.3%的患者;切口疝、输尿管狭窄和动脉狭窄发生率分别为1.4%、1.1%和0.2%。
- 术后第1天、第7天和6个月的中位eGFR分别为19、52和53 ml/min/1.73 m²。
- 中位随访23个月(IQR:6-49)期间,17例接受透析,11例发生移植肾切除,4例死亡;无死亡归因于机器人辅助肾移植。
局限性
- 主要局限性为缺乏对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Evidence regarding perioperative results and long-term functional outcomes of robotic-assisted kidney transplantation (RAKT) is limited. We evaluated perioperative surgical results and long-term functional outcomes of RAKT in patients receiving kidney transplants from living donors. METHODS: This retrospective analysis is based on a prospective multicenter cohort study conducted from July 2015 to October 2023 across ten European centers. A total of 624 patients who underwent heterotopic RAKT from living donors were included, excluding those who received orthotopic RAKT. The primary outcomes measured were long-term renal function, perioperative complications, and survival rates. Renal function was assessed with the estimated glomerular filtration rate (eGFR). The Clavien-Dindo classification (CDC) was used to describe early (within 30 d) and late (from 31 to 90 d) postoperative complications. The probabilities of dialysis, graft nephrectomies, and any-cause mortality during follow-up were reported in terms of the 5-yr cumulative incidence. KEY FINDINGS AND LIMITATIONS: A total of 624 patients with a median age of 35 yr (interquartile range [IQR]: 26-52) underwent RAKT. Preemptive RAKT was performed in 52% of cases, and the majority (84%) had the transplant in the right iliac fossa. The median operative time was 210 min (IQR: 180-262), with a rewarming time of 43 min (IQR: 38-50). Intraoperative complications were rare (1.1%), and postoperative graft nephrectomy occurred in 1.9% of patients. High-grade (CDC grade ≥3) early and late postoperative complications were observed in 7.7% and 2.3% of patients, respectively. Rates of incisional hernias, ureteral stenosis, and arterial stenosis were 1.4%, 1.1%, and 0.2%, respectively. The median eGFR values were 19, 52, and 53 ml/min/1.73 m2 on the 1st postoperative day, on the 7th postoperative day, and at 6 mo, respectively. Over a median follow-up of 23 mo (IQR: 6-49), 17 patients received dialysis, 11 patients underwent graft nephrectomy, and four patients died. None of the deaths were due to RAKT. The main limitation is the absence of a comparator group. CONCLUSIONS AND CLINICAL IMPLICATIONS: With the largest experience worldwide on RAKT, we confirm the perioperative safety and excellent long-term functional outcomes of this procedure. Given the benefits of a minimally invasive robotic approach, these findings support the broader adoption of RAKT as a viable option for kidney transplantation.
引用
- Territo A, Afferi L, Musquera M, et al. Robot-assisted Kidney Transplantation: The 8-year European Experience. Eur Urol. 2025. PMID: 39794184. doi:10.1016/j.eururo.2024.12.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。